Amgen (AMGN) PT Raised to $440 at Cantor Fitzgerald - 'Now a Clear Consensus Long'
Tweet Send to a Friend
Cantor Fitzgerald analyst Carter Gould raised the price target on Amgen (NASDAQ: AMGN) to $440.00 (from $400.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




